Publications

• Wan J, Tanratana P, Roest M, Gruber A, Pawlinski R, Wolberg AS, Mackman N, Grover SP*. A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation. Blood Adv 2023 May;7(9):1915-25.
• Vachiramon V*, Tanratana P, Anuntrangsee T, Palakornkitti P, Yeesibsean N, Kungvalpivat P, Fabi S. The role of topical capsaicin gel in pain management during microfocused ultrasound treatment for neck laxity. Skin Res Technol 2023 Jan;29(1):e13240.
• Tanratana P, Azevedo Sachetto AT, Mackman N*. “A rapid, sensitive, and specific assay to measure tissue
  factor activity based on chromogenic determination of thrombin generation”: comment from Tanratana et al. J Thromb Haemost 2023 Apr;21(4):1059-61.
• Saardpun N, Songsaeng R, Tanratana P, Kusamran T, Pinthong D*. The finding of new in vivo metabolite triptorelin (5-10) in human urine using liquid chromatography coupled with ion trap/time-of-flight mass spectrometry with dimethyl sulfoxide additives in the mobile phase. Molecules 2023 Jun;28(12):4572.
• Grover SP*, Kawano T, Wan J, Tanratana P, Polai Z, Shim YJ, Snir O, Brækkan S, Dhrolia S, Kasthuri RR, Bendapudi PK, McCrae KR, Wolberg AS, Hansen JB, Farkas H, Mackman N. C1 inhibitor deficiency enhances contact pathway–mediated activation of coagulation and venous thrombosis. Blood 2023;141(19):2390-401.
• Saardpun N, Songsaeng R, Tanratana P, Kusamran T, Pinthong D*. The finding of new in vivo metabolite triptorelin (5-10) in human urine using liquid chromatography coupled with ion trap/time-of-flight mass spectrometry with dimethyl sulfoxide additives in the mobile phase. Molecules 2023 Jun;28(12):4572.
• Seanoon K, Payongsri P, Vivithanaporn P, Sirachainan N, Chuansumrit A, Hongeng S*, Tanratana P*. Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency. Blood Adv 2022 Nov;6(22):5887-97.
• Pongjantarasatian S, Kadegasem P, Sasanakul W, Sa-Ngiamsuntorn K, Borwornpinyo S, Sirachainan N, Chuansumrit A, Tanratana P, et al. Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line. PLoS One. 2019;14(8):e0220825.
• Tanratana P, Ellery P, Westmark P, Mast AE, Sheehan JP*. Elevated plasma factor IXa activity in premenopausal women on hormonal contraception. Arterioscler Thromb Vasc Biol 2018 Jan;38(1):266-74.
• Ungprasert P, Tanratana P, Srivali N. Autoimmune hemolytic anemia and venous thromboembolism: A systemic review and meta-analysis. Thromb Res. 2015. DOI: http://dx.doi.org/10.1016/j.thromres. 2015.09.004.
• Westmark PR, Tanratana P, Sheehan JP. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX. J Thromb Haemost. 2015;13(6):1053-63.
• Suvachananonda T, Wankham A, Srihirun S, Tanratana P, Unchern S, Fucharoen S, et al. Decreased nitrite levels in erythrocytes of children with beta-thalassemia/hemoglobin E. Nitric Oxide. 2013;33:1-5.
• Permpalung N, Wongrakpanich S, Korpaisarn S, Tanratana P, Angsanakul J. Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization. Vaccine. 2013;31(38):4079-83.
• Unchern S, Laohareungpanya N, Sanvarinda Y, Pattanapanyasat K, Tanratana P, Chantharaksri U, et al. Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia. Lipids. 2010;45(7):627-33.

Proceedings

• Kado K, Seanoon K, Payongsri P, Korprasertthaworn P, Honging S, Tanratana P. Improved specific coagulant activity of recombinant human factor IX by F9 gene transfection into immortalized hepatocyte-like cell line. In Proceedings of the 37th International Annual Meeting in Pharmaceutical Sciences (IAMPS37). 2022 Mar 24-25; via ZOOM Webinar, Thailand. p. 49-52.